Hemolysis in chronic myelocytic leukemia

D. Scott, A. Theologides

Research output: Contribution to journalArticle

Abstract

The role of hemolysis in the anemia of chronic myelocytic leukemia (CML) remains controversial. The authors reviewed the records of 68 consecutive CML patients to evaluate occurrence and clinical significance of hemolysis. Thirty one (46%) had increased fecal urobilinogen excretion, and this hemolysis group was compared with the remaining 37. There was no difference in age, presence of Philadelphia chromosome, thrombocytopenia, bleeding, occurrence of blast crisis, or chemotherapy in the two groups. There was no correlation between spleen size and hemolysis. Infections and administration of corticosteroids were more frequent in the hemolysis group. Hemolysis was a late complication and had an ominous prognosis, with a temporal association with blast crisis.

Original languageEnglish (US)
Pages (from-to)694-697
Number of pages4
JournalAmerican Journal of Clinical Pathology
Volume65
Issue number5
DOIs
StatePublished - Jan 1 1976

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Hemolysis
Blast Crisis
Urobilinogen
Philadelphia Chromosome
Thrombocytopenia
Anemia
Adrenal Cortex Hormones
Spleen
Hemorrhage
Drug Therapy
Infection

Cite this

Hemolysis in chronic myelocytic leukemia. / Scott, D.; Theologides, A.

In: American Journal of Clinical Pathology, Vol. 65, No. 5, 01.01.1976, p. 694-697.

Research output: Contribution to journalArticle

Scott, D. ; Theologides, A. / Hemolysis in chronic myelocytic leukemia. In: American Journal of Clinical Pathology. 1976 ; Vol. 65, No. 5. pp. 694-697.
@article{a280ea06b4f147fb978b0eca773d63f5,
title = "Hemolysis in chronic myelocytic leukemia",
abstract = "The role of hemolysis in the anemia of chronic myelocytic leukemia (CML) remains controversial. The authors reviewed the records of 68 consecutive CML patients to evaluate occurrence and clinical significance of hemolysis. Thirty one (46{\%}) had increased fecal urobilinogen excretion, and this hemolysis group was compared with the remaining 37. There was no difference in age, presence of Philadelphia chromosome, thrombocytopenia, bleeding, occurrence of blast crisis, or chemotherapy in the two groups. There was no correlation between spleen size and hemolysis. Infections and administration of corticosteroids were more frequent in the hemolysis group. Hemolysis was a late complication and had an ominous prognosis, with a temporal association with blast crisis.",
author = "D. Scott and A. Theologides",
year = "1976",
month = "1",
day = "1",
doi = "10.1093/ajcp/65.5.694",
language = "English (US)",
volume = "65",
pages = "694--697",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "5",

}

TY - JOUR

T1 - Hemolysis in chronic myelocytic leukemia

AU - Scott, D.

AU - Theologides, A.

PY - 1976/1/1

Y1 - 1976/1/1

N2 - The role of hemolysis in the anemia of chronic myelocytic leukemia (CML) remains controversial. The authors reviewed the records of 68 consecutive CML patients to evaluate occurrence and clinical significance of hemolysis. Thirty one (46%) had increased fecal urobilinogen excretion, and this hemolysis group was compared with the remaining 37. There was no difference in age, presence of Philadelphia chromosome, thrombocytopenia, bleeding, occurrence of blast crisis, or chemotherapy in the two groups. There was no correlation between spleen size and hemolysis. Infections and administration of corticosteroids were more frequent in the hemolysis group. Hemolysis was a late complication and had an ominous prognosis, with a temporal association with blast crisis.

AB - The role of hemolysis in the anemia of chronic myelocytic leukemia (CML) remains controversial. The authors reviewed the records of 68 consecutive CML patients to evaluate occurrence and clinical significance of hemolysis. Thirty one (46%) had increased fecal urobilinogen excretion, and this hemolysis group was compared with the remaining 37. There was no difference in age, presence of Philadelphia chromosome, thrombocytopenia, bleeding, occurrence of blast crisis, or chemotherapy in the two groups. There was no correlation between spleen size and hemolysis. Infections and administration of corticosteroids were more frequent in the hemolysis group. Hemolysis was a late complication and had an ominous prognosis, with a temporal association with blast crisis.

UR - http://www.scopus.com/inward/record.url?scp=0017161778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017161778&partnerID=8YFLogxK

U2 - 10.1093/ajcp/65.5.694

DO - 10.1093/ajcp/65.5.694

M3 - Article

VL - 65

SP - 694

EP - 697

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 5

ER -